Archives Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease February 24, 2009 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix funded by the Alzheimer’s Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic developmentNext →Oligomerix Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
